The Kraft Group

The Kraft Family Foundation, based in Foxborough, Massachusetts, is an independent non-profit private foundation established in 1953. It serves as the philanthropic arm of The Kraft Group and is dedicated to supporting higher education initiatives for Jewish organizations, as well as providing assistance to the elderly in Foxborough and surrounding areas. The foundation is governed by a board of directors that manages its assets and ensures that its charitable activities align with its mission to benefit the community. Through its efforts, The Kraft Family Foundation exemplifies a commitment to philanthropy and community support.

Daniel Kraft

President, International

41 past transactions

CAMP4 Therapeutics

Series B in 2022
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to disease treatment, significantly reducing the time and risk to bring new medicines to patients.

Evolved By Nature

Series C in 2022
Evolved By Nature is a biotech company that focuses on creating Activated Silk technology. It is a platform of sustainable silk molecules that reduces reliance on problematic chemicals, builds better supply chains, and vastly increases the performance potential of existing materials to advance the health of people and the planet. Evolved by Nature, based in Boston, was started by biomedical engineer Rebecca Lacouture and chemist Gregory Altman in 2013. Their product is pure silk in liquid form, a regenerative technology made from discarded silkworm cocoons. The company has patented dozens of molecular combinations of the natural silk protein since filing its first application in 2014.

Jackpot

Series A in 2022
Jackpot.com is modernizing the way Americans play the lottery. Jackpot.com brings verified, official state lottery tickets online by leveraging its digital platform to give customers the ability to play right from your phone, tablet, or desktop. Jackpot.com has invested significantly in responsible gaming safeguards, with default spending limits and other features built in throughout the experience, which earned them a certification from the National Council on Problem Gaming. To learn more, visit jackpot.com or download the iOS or Android app.

Relief

Series A in 2022
Relief is a mobile app that delivers on debt-elimination commitment. They aim to become the company that people come to for help getting back in the black. By developing products and services that are simple, effective, and easy to use, they will make financial relief accessible to those who need it.

Evolved By Nature

Series B in 2021
Evolved By Nature is a biotech company that focuses on creating Activated Silk technology. It is a platform of sustainable silk molecules that reduces reliance on problematic chemicals, builds better supply chains, and vastly increases the performance potential of existing materials to advance the health of people and the planet. Evolved by Nature, based in Boston, was started by biomedical engineer Rebecca Lacouture and chemist Gregory Altman in 2013. Their product is pure silk in liquid form, a regenerative technology made from discarded silkworm cocoons. The company has patented dozens of molecular combinations of the natural silk protein since filing its first application in 2014.

Mythical Games

Series C in 2021
Mythical is a next-generation game technology studio. Mythical Games believes that true ownership of digital assets, verifiable scarcity, and integrated secondary markets will spawn a new generation of games. These new economies, based on digital ownership, will bring players, developers, and content creators closer to the games they love. Mythical Games has a team of veteran game and platform developers with a passion for bringing big innovative concepts to market. Its goal is to create world-class products that drive consumer adoption of distributed ledger technology through games.

CAMP4 Therapeutics

Series A in 2021
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to disease treatment, significantly reducing the time and risk to bring new medicines to patients.

Premier Lacrosse League

Series C in 2021
Premier Lacrosse League is the biggest stars in the fastest growing sport pioneering a new future for lacrosse designed for the fans. They sell sports-related clothes online.

Rowdy Energy

Funding Round in 2021
Rowdy Energy is a drink industry business that specializes in energy drinks. It combines caffeine with the nootropic L-Theanine to provide a powerful boost without the unwelcome and irritable crash. The company's L-Theanine gives the laser focus on the need to conquer any challenge. Electrolytes keep the body hydrated and running at peak performance. Rowdy Energy Drink is currently available in ten flavors, including seven sugar-free, KETO-certified options.
ProMIS Neurosciences is a development-stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). It was founded in 2004 and headquartered in Toronto, Canada.

River

Series A in 2021
River Financial is a challenger financial institution specializing in Bitcoin financial services. River Financial's flagship product, a Bitcoin brokerage, provides sophisticated retail investors with a high-touch platform to buy and sell Bitcoin. Founded in 2019 by Alexander Leishman and Andrew Benson, River's brokerage product provides its clients with best-in-class security, a world-class client service experience, and investment performance tools such as cost basis tracking.

Songclip (Audiobyte)

Venture Round in 2021
Songclip™ is a new licensed music format built specifically for texting, social posts, and quick communication. Songclip’s multi-patented networked product solution, the Songclip API, integrates seamlessly into social platforms, mobile apps, and virtual marketplaces to drive expression, monetization, and music streaming. Songclip operates the world’s foremost searchable library of 5-30 second meta-tagged music clips, in partnership with the music industry. For more information, visit songclip.com
Controllable Language Models™

Butler Hospitality

Series A in 2020
Butler Hospitality is an on-demand platform for room service and amenities. Butler Hospitality delivers amazing gourmet amenities right to any hotel room and specializes in providing offsite room service for limited-service hotels. Butler Hospitality was founded in 2017 in New York City.

Silk Therapeutics

Series B in 2018
Silk Therapeutics develops, manufactures, and sells skincare products based on silk materials. It offers PureProC, a film formulation that surrounds, protects, stabilizes, and delivers the benefits of vitamin C for an extended duration with anti-aging and skin health benefits. The company sells its products through its online store. Silk Therapeutics skincare line features clean, highly effective anti-aging skincare and skin health products that are healthy enough to use on any skin type, including highly sensitive skin. The company's proprietary liquid silk technology platform was developed by company co-founders Greg Altman, Ph.D., and Rebecca Horan, Ph.D., foremost experts in the use of silk for health and wellness solutions—including effective stabilization and delivery of real silk molecules to the skin. Silk Therapeutics, Inc. was incorporated in 2013 and is based in Medford, Massachusetts.

CAMP4 Therapeutics

Series A in 2018
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to disease treatment, significantly reducing the time and risk to bring new medicines to patients.

Scholar Rock

Series C in 2018
Scholar Rock is a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company's newly elucidated understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. They believe this approach, acting in the disease microenvironment, avoids the historical challenges associated with inhibiting growth factors for therapeutic effect. We believe our focus on biologically validated growth factors may facilitate a more efficient development path. The company is advancing its lead product candidate, SRK-015, a selective first-in-class inhibitor of the activation of the growth factor myostatin in skeletal muscle, into clinical development for the treatment of spinal muscular atrophy, or SMA. They expect to initiate a Phase 1 clinical trial in the second quarter of 2018. Utilizing its proprietary platform, they are also creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including other neuromuscular disorders, cancer, fibrosis, and anemia.

Silk Therapeutics

Series A in 2017
Silk Therapeutics develops, manufactures, and sells skincare products based on silk materials. It offers PureProC, a film formulation that surrounds, protects, stabilizes, and delivers the benefits of vitamin C for an extended duration with anti-aging and skin health benefits. The company sells its products through its online store. Silk Therapeutics skincare line features clean, highly effective anti-aging skincare and skin health products that are healthy enough to use on any skin type, including highly sensitive skin. The company's proprietary liquid silk technology platform was developed by company co-founders Greg Altman, Ph.D., and Rebecca Horan, Ph.D., foremost experts in the use of silk for health and wellness solutions—including effective stabilization and delivery of real silk molecules to the skin. Silk Therapeutics, Inc. was incorporated in 2013 and is based in Medford, Massachusetts.

Dune Medical Devices

Series D in 2017
Dune Medical Devices was founded in 2002 to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the ability to detect cancer in real time, this technology holds promise for a broad range of diagnostic and therapeutic applications. Surgeons who fight cancer on a daily basis must always contend with the lingering question, “Did I get it all?” It forces those who tackle breast cancer to consistently balance the imperative towards aggressive treatment with the desire to conserve tissue. A critical leveler in that struggle may be MarginProbe™ from Dune Medical. The MarginProbe™ System delivers real-time cancer detection in the OR for a simple and immediate assessment of cancer on the margin of excised tissue. In a randomized study of 300 breast cancer patients in Israel, the reoperation rate was reduced by 56% vs. standard of care when the MarginProbe System was employed.

Spero Therapeutics

Series C in 2017
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Its lead program addresses a novel target driving virulence and persistence of pseudomonas aeruginosa infections and other gram-negative pathogens.

Silk Therapeutics

Series A in 2016
Silk Therapeutics develops, manufactures, and sells skincare products based on silk materials. It offers PureProC, a film formulation that surrounds, protects, stabilizes, and delivers the benefits of vitamin C for an extended duration with anti-aging and skin health benefits. The company sells its products through its online store. Silk Therapeutics skincare line features clean, highly effective anti-aging skincare and skin health products that are healthy enough to use on any skin type, including highly sensitive skin. The company's proprietary liquid silk technology platform was developed by company co-founders Greg Altman, Ph.D., and Rebecca Horan, Ph.D., foremost experts in the use of silk for health and wellness solutions—including effective stabilization and delivery of real silk molecules to the skin. Silk Therapeutics, Inc. was incorporated in 2013 and is based in Medford, Massachusetts.

Spero Therapeutics

Series B in 2016
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Its lead program addresses a novel target driving virulence and persistence of pseudomonas aeruginosa infections and other gram-negative pathogens.

Skillz

Series B in 2015
Skillz is the mobile games platform on a mission to bring out the best in everyone through fun and fair competition. The Skillz platform helps developers create multi-million dollar franchises by enabling social competition in their games. Leveraging its patented technology, Skillz hosts billions of casual mobile gaming tournaments for millions of players worldwide. As the pioneer of skill-based competition for mobile gaming, Skillz has earned recognition with Parity.Org’s 2022 Best Companies for Women to Advance, Deloitte 2022 Tech Fast 500 and one of Fast Company’s Most Innovative Companies in 2023.

DraftKings

Series D in 2015
DraftKings provides online daily and weekly fantasy sports contests for cash prizes in major sports in the United States and Canada. It offers daily leagues for fantasy football, baseball, basketball, hockey, golf, college football, and college basketball.

Delphix

Series D in 2015
Delphix provides an intelligent data platform that accelerates digital transformation for companies around the world. Its DataOps platform supports a broad spectrum of systems from mainframes to Oracle databases, ERP applications, and Kubernetes containers. The company was founded in 2008 and is headquartered in Redwood City, California.

Spero Therapeutics

Series A in 2015
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Its lead program addresses a novel target driving virulence and persistence of pseudomonas aeruginosa infections and other gram-negative pathogens.

Silk Therapeutics

Series A in 2015
Silk Therapeutics develops, manufactures, and sells skincare products based on silk materials. It offers PureProC, a film formulation that surrounds, protects, stabilizes, and delivers the benefits of vitamin C for an extended duration with anti-aging and skin health benefits. The company sells its products through its online store. Silk Therapeutics skincare line features clean, highly effective anti-aging skincare and skin health products that are healthy enough to use on any skin type, including highly sensitive skin. The company's proprietary liquid silk technology platform was developed by company co-founders Greg Altman, Ph.D., and Rebecca Horan, Ph.D., foremost experts in the use of silk for health and wellness solutions—including effective stabilization and delivery of real silk molecules to the skin. Silk Therapeutics, Inc. was incorporated in 2013 and is based in Medford, Massachusetts.

Lineage Labs

Seed Round in 2015
We are inventors, marketers, consumers, photo buffs, friends, and co-workers. We are dedicated to helping you tell your family's stories. Whether it’s a picture from a day at the beach, or a video of the dog chasing a squirrel, there exists a special, unique story behind all of these images. But too often, due to our busy lives, these stories remain locked away on our digital devices, rarely finding the right way or the right time to be shared and enjoyed.

Scholar Rock

Series A in 2014
Scholar Rock is a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company's newly elucidated understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. They believe this approach, acting in the disease microenvironment, avoids the historical challenges associated with inhibiting growth factors for therapeutic effect. We believe our focus on biologically validated growth factors may facilitate a more efficient development path. The company is advancing its lead product candidate, SRK-015, a selective first-in-class inhibitor of the activation of the growth factor myostatin in skeletal muscle, into clinical development for the treatment of spinal muscular atrophy, or SMA. They expect to initiate a Phase 1 clinical trial in the second quarter of 2018. Utilizing its proprietary platform, they are also creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including other neuromuscular disorders, cancer, fibrosis, and anemia.

Dune Medical Devices

Series C in 2014
Dune Medical Devices was founded in 2002 to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the ability to detect cancer in real time, this technology holds promise for a broad range of diagnostic and therapeutic applications. Surgeons who fight cancer on a daily basis must always contend with the lingering question, “Did I get it all?” It forces those who tackle breast cancer to consistently balance the imperative towards aggressive treatment with the desire to conserve tissue. A critical leveler in that struggle may be MarginProbe™ from Dune Medical. The MarginProbe™ System delivers real-time cancer detection in the OR for a simple and immediate assessment of cancer on the margin of excised tissue. In a randomized study of 300 breast cancer patients in Israel, the reoperation rate was reduced by 56% vs. standard of care when the MarginProbe System was employed.

Sample6

Series B in 2013
Sample6 is a synthetic-biology based bacteria diagnostic system capable of enrichment-free detection. Its technology detects as low as 1CFU/ml in just 4 hours. Its proprietary Bioillumination Platform was developed by Professor Tim Lu (MIT) and Dr. Michael Koeris in the lab of Professor James Collins at the Howard Hughes Medical Institute and Boston University. The platform allows for the engineering of bioparticles that target and “light up” specific unwanted bacteria—or specific groups of bacterial species. They couple this capability with highly sensitive sensor technology that detects low levels of pathogens to see results in minutes—right on-site—with no laboratory required. Sample6′s mission is to improve the health and safety of global consumers by building integrated systems that quickly and easily detect harmful and unwanted bacteria. They see applications in food production, retailing, healthcare, and beyond—anywhere humans and bacteria intersect.

SynapDx

Venture Round in 2013
SynapDx's mission is to provide laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. Autism Spectrum Disorders are currently estimated to affect 1 in 110 children in the United States according to the Centers for Disease Control. SynapDx was founded by Stanley Lapidus and closed a Series A round of venture funding in May 2010 from North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners. SynapDx's corporate headquarters is located in Lexington, Massachusetts.

SynapDx

Venture Round in 2013
SynapDx's mission is to provide laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. Autism Spectrum Disorders are currently estimated to affect 1 in 110 children in the United States according to the Centers for Disease Control. SynapDx was founded by Stanley Lapidus and closed a Series A round of venture funding in May 2010 from North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners. SynapDx's corporate headquarters is located in Lexington, Massachusetts.

New-Indy Containerboard

Seed Round in 2013
New-Indy Containerboard is a manufacturer and supplier of recycled containerboard to the corrugated box industry. New-Indy is a joint-venture that was formed in 2012 by the Kraft Group and Schwarz Partners, LP, two family-owned companies with long histories in paper and packaging. Today, New-Indy operates three recycled brown paper mills and eight packaging facilities throughout the United States.

Humedica

Venture Round in 2012
Humedica is the clinical intelligence company that powers health care providers and life sciences organ izations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.

Blog Talk Radio

Series B in 2010
BlogTalkRadio, founded in 2006, is a site where anyone can set up a podcast or "radio talkshow" over the web. Users are given a phone number and can allow anyone to join (and optionally participate) in the call.

Patriot Place

Venture Round in 2010
Patriot Place is a lifestyle center that offers dining, lodging, hospitality, shopping, entertainment and health care.

Acetylon Pharmaceuticals

Series A in 2009
Acetylon Pharmaceuticals, Inc. intends to manufacture small molecule drugs to realize the therapeutic potential of histone deacetylase. The company was incorporated in 2008 and is based in Boston, Massachusetts.

Blog Talk Radio

Series A in 2008
BlogTalkRadio, founded in 2006, is a site where anyone can set up a podcast or "radio talkshow" over the web. Users are given a phone number and can allow anyone to join (and optionally participate) in the call.

MatchMine

Series A in 2007
MatchMine is a media recommendation service that categorizes and analyzes your media likes and dislikes in order to serve you content that is more to your taste. Through its "MatchKey" technology, Matchmine uses demographic information about each user combined with a rating system to recommend media based upon your past media consumption. MatchMine will support three 3rd party sites at its launch which include Peerflix, FilmCrave and Fuzz.com. Like a [Last.FM](http://crunchbase.com/organization/Last.FM) for video, music, movies and blogs, MatchMine seeks to help you discover your new favorite media. Although their are no direct competitors, it will be interesting to see if CBS, which acquired Last.FM in May of 2007, uses Last.FM's recommendation engine for its own TV content. Additionally, [StumbleUpon](http://crunchbase.com/organization/stumbleupon) functions comparably by recommending media based on your previous ratings of similar media.

Httprint

Series C in 2000
httprint is a total service provider to the printing industry. Their enabling technology allows print buyers and sellers to save time and money by streamlining the procurement and management process. Their heritage of outsourcing print management gives their customers a ready team of experts they can rely on to support or manage any project. Their integrated Web-site environment enables both buyers and suppliers to communicate and complete transactions on-line from anywhere in the world. This Internet-based solution powers your existing web site or intranet giving you a single hub where all of your purchasing activities can be centralized. Their professional services team is made up of print professionals able to assist your existing team of buyers on any or all phases of the print transaction. They are available through their online chat feature where your questions are answered instantly and are also available to completely manage any or all of your projects on a fully outsourced basis. Their customers find that by utilizing their team of experts they save time and money over doing it themselves. httprint has its roots in Landmark Productions, a brick and mortar print production company that was renamed httprint in January 2000. Landmark Productions had built a solid reputation in the print industry by serving companies that lacked the resources, time, or expertise to perform print services for themselves. Much of what was learned in providing services in the bricks-and-mortar world was proceduralized and migrated to the Web at www.httprint.com. httprint is a total resource for buyers and suppliers in the print industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.